| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
Channel Therapeutics Corp
13G
CHRO · 171126105
|
9.5% |
1/15/2025
Event 12/13/2024
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.